Serum carnosinase deficiency: a non-disabling phenotype?

Serum carnosinase deficiency (McKusick 21220) is a rare condition, described in 13 cases. Ten additional individuals with serum carnosinase deficiency have been identified. All continued to excrete increased amounts of carnosine in their urine despite a meat-free diet for 3 days. Serum carnosinase activity ranged from 0-30% of normal. In four individuals a normal Km for carnosine of 0.12 mM was observed, while in five individuals an increased Km was found. Homocarnosine levels in CSF in three individuals ranged from 3.4 to 15 mM. Clinical symptoms in these individuals were as follows: attention deficit disorder: 4; non progressive developmental delay: 1; neurofibromatosis: 1; absences seizures: 1; severe, but non-progressive mental retardation, seizures and neurosensory hearing loss: 1; progressive childhood dementia; 1; clinically normal: 1. There was no correlation between severity and type of the neurological symptoms and residual serum carnosinase activity. Although a definite conclusion can only be made after a considerably higher number of individuals has been analyzed, the suspicion that serum carnosinase deficiency is unrelated to the neurological symptoms is strengthened by these observations. There may, however, be an association with a predisposition for mental deficiency.

[1]  Hiroshi Takahashi Studies on homocarnosine in cerebrospinal fluid in infancy and childhood. Part I. Homocarnosine level in cerebrospinal fluid of normal infants and children , 1981, Brain and Development.

[2]  J. Charvet,et al.  [Carnosinemia. First French case]. , 1980, Pediatrie.

[3]  K. Wisniewski,et al.  Carnosinase Deficiency: a New Variant with High Residual Activity , 1980, Pediatric Research.

[4]  A. Fluharty,et al.  Cerebroside sulfate hydrolysis by fibroblasts from a parent with metachromatic leukodystrophy. , 1978, The Journal of pediatrics.

[5]  H. Levy,et al.  A VARIANT OF CARNOSINEMIA WITH NORMAL SERUM CARNOSINASE ACTIVITY IN AN INFANT , 1977, Pediatric Research.

[6]  J. Berstad,et al.  HOMOCARNOSINOSIS. 3 SPINAL FLUID AMINO ACIDS IN FAMILIAL SPASTIC PARAPLEGIA , 1977, Acta neurologica Scandinavica.

[7]  J. Berstad,et al.  HOMOCARNOSINOSIS. 2. A FAMILIAL METABOLIC DISORDER ASSOCIATED WITH SPASTIC PARAPLEGIA, PROGRESSIVE MENTAL DEFICIENCY, and RETINAL PIGMENTATION , 1976, Acta neurologica Scandinavica.

[8]  N. Baumann,et al.  Letter: Absence of ASA activity in healthy father of a patient with metachromatic leukodystrophy. , 1975, The New England journal of medicine.

[9]  E. Burgess,et al.  Plasma carnosinase deficiency in patients with urea cycle defects. , 1975, Clinica chimica acta; international journal of clinical chemistry.

[10]  L. Gjessing,et al.  HOMOCARNOSINOSIS: A NEW METABOLIC DISORDER ASSOCIATED WITH SPASTICITY AND MENTAL RETARDATION , 1974 .

[11]  L. Mosovich,et al.  Serum Carnosinase Deficiency Concomitant with Mental Retardation , 1973, Pediatric Research.

[12]  D. Lindmark,et al.  Carnosinase: A fluorometric assay and demonstration of two electrophoretic forms in human tissue extracts☆ , 1972 .

[13]  K. Terplán,et al.  Histopathology of the nervous system in carnosinase enzyme deficiency with mental retardation , 1972, Neurology.

[14]  L. Monnens,et al.  A PATIENT WITH A DEFICIENCY OF SERUM‐CARNOSINASE ACTIVITY , 1969, Acta paediatrica Scandinavica.

[15]  D. Hsia,et al.  Atypical phenylketonuria with borderline or normal intelligence. , 1968, American journal of diseases of children.

[16]  T. Perry,et al.  Carnosinemia. A new metabolic disorder associated with neurologic disease and mental defect. , 1967, The New England journal of medicine.

[17]  E. Podoll,et al.  ABOVE AVERAGE INTELLIGENCE IN UNTREATED PHENYLKETONURIA. , 1963, The Journal of pediatrics.